Want to see IH full AI Analyst Report?
IH Stock Chart & Stats
$2.00
-$0.07(-4.34%)
At close: 4:00 PM EST
$2.00
-$0.07(-4.34%)
Day’s Range― - ―
52-Week Range$1.12 - $3.09
Previous CloseN/A
Volume8.51K
Average Volume (3M)9.65K
Market Cap
$58.78M
Enterprise Value-$67.17
Total Cash (Recent Filing)$1.10B
Total Debt (Recent Filing)$10.92M
Price to Earnings (P/E)1.1
Beta0.43
Next Earnings
Dec 17, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend Yield8.77%
Share Statistics
EPS (TTM)7.14
Shares Outstanding22,312,862
10 Day Avg. Volume6,211
30 Day Avg. Volume9,649
Financial Highlights & Ratios
PEG Ratio-0.51
Price to Book (P/B)0.15
Price to Sales (P/S)0.19
P/FCF Ratio3.34
Enterprise Value/Market Cap>-0.01
Enterprise Value/Revenue>-0.01
Enterprise Value/Gross Profit>-0.01
Enterprise Value/Ebitda>-0.01
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Bulls Say, Bears Say
Bulls Say
Very Low LeverageMinimal debt and a large equity base reduce financial risk, preserve liquidity for product investment, and give iHuman flexibility to fund AI development, acquisitions, and international expansion without substantial interest or refinancing pressure.
Strong Gross MarginsSustained high gross margins support the economics of iHuman’s subscription-led digital model. They provide room to invest in content, marketing, and AI capabilities while retaining the potential to rebuild profitability as adoption and scale improve.
AI Ecosystem ExpansionThe acquisitions broaden iHuman’s age coverage, subject breadth, and AI capabilities beyond its core children’s products. Combined with new strategic leadership, they could increase cross-selling opportunities and strengthen the platform’s long-term competitive position.
Bears Say
Sustained Revenue ContractionTwo consecutive years of declining revenue indicate weaker demand and make future growth less predictable. The contraction can limit operating leverage, reduce resources available for innovation, and challenge the company’s ability to convert its broad product base into durable expansion.
Demographic And User HeadwindsChina’s declining newborn population creates a structural constraint for a business focused on children’s education. Falling monthly active users and softer consumer spending also weaken the addressable base, making sustained subscriber growth and efficient customer acquisition more difficult.
Weaker Profit And Cash ConversionThe sharp decline in operating cash generation, weaker 2025 cash conversion, and latest operating loss reduce internally funded investment capacity. If this persists, iHuman may need to moderate strategic spending or rely more heavily on its balance-sheet resources.
IH FAQ
What was iHuman’s price range in the past 12 months?
iHuman lowest stock price was $1.12 and its highest was $3.09 in the past 12 months.
What is iHuman’s market cap?
iHuman’s market cap is $58.78M.
When is iHuman’s upcoming earnings report date?
iHuman’s upcoming earnings report date is Dec 17, 2026 which is in 84 days.
How were iHuman’s earnings last quarter?
iHuman released its earnings results on Jun 29, 2026. The company reported $0.013 earnings per share for the quarter.
Is iHuman overvalued?
According to Wall Street analysts iHuman’s price is currently Overvalued.
Does iHuman pay dividends?
iHuman pays a Notavailable dividend of $0.1 which represents an annual dividend yield of 8.77%. See more information on iHuman dividends here
What is iHuman’s EPS estimate?
iHuman’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does iHuman have?
iHuman has 22,312,862 shares outstanding.
What happened to iHuman’s price movement after its last earnings report?
iHuman reported an EPS of $0.013 in its last earnings report. Following the earnings report the stock price went up 0.855%.
Which hedge fund is a major shareholder of iHuman?
Currently, no hedge funds are holding shares in IH
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
iHuman
Operating within the People's Republic of China, iHuman Inc. specializes in delivering educational resources aimed at fostering cognitive growth. Their offerings reach a broad audience, encompassing individual consumers, early learning institutions, and wholesale distributors. A significant portion of their portfolio consists of interactive and self-guided digital applications. These include popular titles such as iHuman Chinese, iHuman ABC, iHuman Pinyin, iHuman Magic Thinking, iHuman Books, iHuman Stories, iHuman Reading, iHumanpedia, iHuman Kids Workout, iHuman Coding, iHuman Fun Idioms, iHuman Little Artists, and iHuman Readers. Beyond digital platforms, iHuman Inc. also furnishes a diverse array of physical educational content, ranging from books and interactive tools to smart devices. These resources are specifically designed to cultivate essential childhood skills, such as verbal communication, analytical reasoning, autonomous reading, and creative expression. Established in 1996, the company maintains its headquarters in Beijing, located within the People's Republic of China.
Technical Analysis
New Oriental Education Tech
―
China Online Education Group
―
TAL Education Group
―
Gaotu Techedu
―
17 Education & Technology Group
―
Ownership Overview
―
Insiders
―
Mutual Funds
0.09% Other Institutional Investors
99.91% Public Companies and
Individual Investors












